Factors that may affect the response of onychomycosis to oral antifungal therapy

Australas J Dermatol. 1998 Nov;39(4):222-4. doi: 10.1111/j.1440-0960.1998.tb01477.x.

Abstract

With the advent of the newer oral antifungals available to treat onychomycosis, the majority of patients respond to therapy. However, there may be subsets of patients who exhibit poor response or failure. Possible explanations for this may be grouped into categories, including: (i) patient characteristics; (ii) organisms causing or associated with the nail infection; (iii) nail characteristics; and (iv) local diseases involving the nail.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use*
  • Drug Interactions
  • Female
  • Humans
  • Male
  • Nails / microbiology
  • Nails / pathology
  • Onychomycosis / drug therapy*
  • Patient Compliance

Substances

  • Antifungal Agents